Skyhawk Therapeutics lands $40 mln
Waltham, Massachusetts-based Skyhawk Therapeutics Inc, a developer of small molecule therapeutics that correct RNA expression, has secured $40 million in funding. The company's investors include Alexandria Venture Investments, GreatPoint Ventures, ShangPharma Innovation and Agent Capital.
26 June 2018•1 min read
